Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Use of Next Generation Sequencing Panel for Routine Diagnosis of Hereditary Hemolytic Anemias

Archana M Agarwal, MD, Jay L Patel, MD, Adam Clayton, PhD, Noel Scott Reading, PhD

Blood (2018) 132 (Supplement 1): 2325.

https://doi.org/10.1182/blood-2018-99-112589

Published: 2018

Journal Articles

The Pharmacokinetics (PK) of GBT440 Following Single Doses in Pediatric Patients with Sickle Cell Disease (SCD)

Carla B Washington, PhD, Michelle Green, PhD, Adlette C. Inati, MD, Clark Brown, MD PhD, Carolyn C Hoppe, MD, Winfred Wang, MD, Ganesh Balaratnam, MD, Sandra Dixon, MS, Erica Fong, Athiwat Hutchaleelaha, PhD, Margaret E Tonda, PharmD, Josh Lehrer, MD MPhil, FACC

Blood (2017) 130 (Supplement 1): 980.

https://doi.org/10.1182/blood.V130.Suppl_1.980.980

Published: 2017

Journal Articles

Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning

Jung Yoon Choi, MD, Heewon Seo, Yoomi Park, ByungJoo Min, Hyery Kim, MD, Kyung Taek Hong, MD, Che Ry Hong, MD, Sang Hoon Song, MD, Kyung-Sang Yu, MD, In-Jin Jang, MD, Kyung Duk Park, MD, Hee Young Shin, MD, Ju Han Kim, MD, Hyoung Jin Kang, MD

Blood (2017) 130 (Supplement 1): 1963.

https://doi.org/10.1182/blood.V130.Suppl_1.1963.1963

Published: 2017

Journal Articles

The Association of Gilbert's Syndrome with Hyperbilirubinaemia Occurring on Any of Imatinib, Dasatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia (CML)

Jeeyune Bahk, BSc, Simone Claudiani, MD, Richard M Szydlo, BSc, PhD, Sarmad Toma, BSc, Faisal Abdillah, BSc, Sandra Hing, BSc, Simona Deplano, MDPhD, Dragana Milojkovic, Jane F Apperley, MD, Letizia Foroni, MD PhD

Blood (2015) 126 (23): 2795.

https://doi.org/10.1182/blood.V126.23.2795.2795

Published: 2015

Journal Articles

Polymorphism of UGT1A1 and Frequency of Hyperbilirubinemia in Patients with Chronic Myeloid Leukemia Treated By Nilotinib

Anastasia Bykova, MD, Adhamjon Abdullaev, MD PhD, Galina Gusarova, MD PhD, Ekaterina Chelysheva, MD PhD, Svetlana Treglazova, MD, Svetlana Smirnova, MD, Anna G. Turkina, MD PhD

Blood (2014) 124 (21): 5538.

https://doi.org/10.1182/blood.V124.21.5538.5538

Published: 2014

Journal Articles

Distinct Associations Between UGT1A1 Gene Promoter Polymorphism and Hyperbilirubinemia in Korean CML Patients Treated with Nilotinib and Radotinib

Soo-Hyun Kim, Soo Young Choi, Sung-Eun Lee, Yun Jeong Oh, Hae Lyun Yoo, Eun-Jung Jang, Mi-yeon Choi, Moon-mi Jang, Hyeoung Joon Kim, MD, Jae-Yong Kwak, MD PhD, Hawk Kim, MD, PhD., Young-Rok Do, PhD, Dong-Wook Kim, MD PhD

Blood (2014) 124 (21): 5511.

https://doi.org/10.1182/blood.V124.21.5511.5511

Published: 2014

Journal Articles

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia

Michaela Gruber, Judith Bellemare, Gregor Hoermann, Andreas Gleiss, Edit Porpaczy, Martin Bilban, Trang Le, Sonja Zehetmayer, Christine Mannhalter, Alexander Gaiger, Medhat Shehata, Karin Fleiss, Cathrin Skrabs, Éric Lévesque, Katrina Vanura, Chantal Guillemette, Ulrich Jaeger

Blood (2013) 121 (7): 1175–1183.

https://doi.org/10.1182/blood-2012-08-447359

Published: 2013

Includes: Supplemental data

Journal Articles

UGT2B17 as a disease accelerator in CLL

Yiming Zhong, John C. Byrd

Blood (2013) 121 (7): 1067–1068.

https://doi.org/10.1182/blood-2012-12-469965

Published: 2013

Journal Articles

Vorinostat (SAHA), Cladribine, and Rituximab in Previously Untreated Mantle Cell Lymphoma: Updated Results From a Phase I/II Trial

Stephen E Spurgeon, MD, Kamal Sharma, DO, David F. Claxton, MD, Christopher W. Ehmann, MD, Carla Gallagher, PhD, Sara Shimko, BS, August Stewart, Samir Parekh, MD, Violetta V. Leshchenko, PhD, Yiyi Chen, PhD, Elliot M Epner, MD, PhD

Blood (2012) 120 (21): 3675.

https://doi.org/10.1182/blood.V120.21.3675.3675

Published: 2012

Journal Articles

Gallstones in a Newborn-Cohort with Sickle Cell Anemia (SCA): Cumulative Risk and Predictive Factors

Annie Kamdem, Cécile Arnaud, Nadia Médejel, Clément Tassel, Isabelle Hau, Serge Pissard, Francoise Bernaudin

Blood (2011) 118 (21): 513.

https://doi.org/10.1182/blood.V118.21.513.513

Published: 2011

Journal Articles

Gene Expression Profiling of Diffuse Large B-Cell Lymphomas Supervised by CD5 Expression

Kana Miyazaki, MD, PhD, Motoko Yamaguchi, MD, PhD, Hiroshi Imai, MD, PhD, Satoshi Tamaru, MD, PhD, Tohru Kobayashi, MD, PhD, Hiroshi Shiku, MD, PhD, Naoyuki Katayama, MD, PhD

Blood (2010) 116 (21): 4164.

https://doi.org/10.1182/blood.V116.21.4164.4164

Published: 2010

Journal Articles

UDP Glucuronosyltransferase 2B17 Double Deletion Genotype Is An Independent Marker for Poor Prognosis In Multiple Myeloma

Michaela Gruber, Sandra Eder, Trang Le, Jutta Ackermann, Katrina Vanura, Ulrich Jaeger, Johannes Drach

Blood (2010) 116 (21): 2955.

https://doi.org/10.1182/blood.V116.21.2955.2955

Published: 2010

Journal Articles

Phenobarbital for Long-Term Management of Marked Hyperbilirubinemia.

A. Majid Shojania, MD

Blood (2009) 114 (22): 5089.

https://doi.org/10.1182/blood.V114.22.5089.5089

Published: 2009

Journal Articles

Pharmacogenetics of Mycophenolate Mofetil in Patients Undergoing Hematopoietic Cell Transplantation (HCT).

Janel Long, PharmD, William S. Oetting, PhD, Wang Xinjing, MD, PhD, Xianghua Luo, PhD, Marcie Tomblyn, MD, Daniel Weisdorf, MD, Pamala Jacobson, PharmD

Blood (2007) 110 (11): 3010.

https://doi.org/10.1182/blood.V110.11.3010.3010

Published: 2007

Journal Articles

Ancestry and pharmacogenetics of antileukemic drug toxicity

Shinji Kishi, Cheng Cheng, Deborah French, Deqing Pei, Soma Das, Edwin H. Cook, Nobuko Hijiya, Carmelo Rizzari, Gary L. Rosner, Tony Frudakis, Ching-Hon Pui, William E. Evans, Mary V. Relling

Blood (2007) 109 (10): 4151–4157.

https://doi.org/10.1182/blood-2006-10-054528

Published: 2007

Includes: Supplemental data

Journal Articles

The Interaction of UGT1A, HO1 and α-Thalassemia Variants with Bilirubin Levels and Gallstones in Sickle Cell Disease.

Nisha Vasavda, PhD, Stephan Menzel, MD, Sheila Kondaveeti, PhD, Emma Maytham, BSc, Moji Awogbade, BMedSc,MRCP, MRCPath, Sybil Bannister, RN, BSN, Juliette Cunningham, Yvonne Daniel, PhD, Iheanyi Okpala, MRCP, MRCPath, Tony Fulford, PhD, Swee Lay Thein, FRCP,FRCPath,DSc

Blood (2006) 108 (11): 1202.

https://doi.org/10.1182/blood.V108.11.1202.1202

Published: 2006

Journal Articles

UGT1A8 and UGT1A9 as Molecular Determinants of Mycophenolate Mofetil (MMF) Pharmacokinetics.

Eric Levesque, MD, PhD, Robert Delage, MD,MSC, Marie-Odile Benoit Biancamano, MSC, Felix Couture, MD, Chantal Guillemette, PhD

Blood (2006) 108 (11): 3191.

https://doi.org/10.1182/blood.V108.11.3191.3191

Published: 2006

Journal Articles

Pharmacogenomics of Deferiprone Metabolism.

Eden V. Haverfield, PhD, David J. Weatherall, MD, Andrea Yoder Graber, BA, Jacqueline Ramirez, MS, Mark J. Ratain, MD

Blood (2005) 106 (11): 2703.

https://doi.org/10.1182/blood.V106.11.2703.2703

Published: 2005

Journal Articles

Pharmacokinetics (PK) of Mycophenolate Mofetil (MMF) in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients Are Associated with Significantly Higher Clearance.

Olga Militano, Kate Roache, Leslie M. Shaw, Michael Figurski, Prakash Satwani, Janet Ayello, Karen Wolownik, Sandra Foley, Ria Hawkes, Gustavo Del Toro, M. Brigid Bradley, Diane George, James Garvin, Monica Bhatia, Liz Roman, Mitchell S. Cairo

Blood (2005) 106 (11): 1823.

https://doi.org/10.1182/blood.V106.11.1823.1823

Published: 2005

NARROW

Use of Next Generation Sequencing Panel for Routine Diagnosis of Hereditary Hemolytic Anemias

The Pharmacokinetics (PK) of GBT440 Following Single Doses in Pediatric Patients with Sickle Cell Disease (SCD)

Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning

The Association of Gilbert's Syndrome with Hyperbilirubinaemia Occurring on Any of Imatinib, Dasatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia (CML)

Polymorphism of UGT1A1 and Frequency of Hyperbilirubinemia in Patients with Chronic Myeloid Leukemia Treated By Nilotinib

Distinct Associations Between UGT1A1 Gene Promoter Polymorphism and Hyperbilirubinemia in Korean CML Patients Treated with Nilotinib and Radotinib

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia

UGT2B17 as a disease accelerator in CLL

Vorinostat (SAHA), Cladribine, and Rituximab in Previously Untreated Mantle Cell Lymphoma: Updated Results From a Phase I/II Trial

Gallstones in a Newborn-Cohort with Sickle Cell Anemia (SCA): Cumulative Risk and Predictive Factors

Gene Expression Profiling of Diffuse Large B-Cell Lymphomas Supervised by CD5 Expression

UDP Glucuronosyltransferase 2B17 Double Deletion Genotype Is An Independent Marker for Poor Prognosis In Multiple Myeloma

Phenobarbital for Long-Term Management of Marked Hyperbilirubinemia.

Pharmacogenetics of Mycophenolate Mofetil in Patients Undergoing Hematopoietic Cell Transplantation (HCT).

Ancestry and pharmacogenetics of antileukemic drug toxicity

The Interaction of UGT1A, HO1 and α-Thalassemia Variants with Bilirubin Levels and Gallstones in Sickle Cell Disease.

UGT1A8 and UGT1A9 as Molecular Determinants of Mycophenolate Mofetil (MMF) Pharmacokinetics.

Pharmacogenomics of Deferiprone Metabolism.

Pharmacokinetics (PK) of Mycophenolate Mofetil (MMF) in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients Are Associated with Significantly Higher Clearance.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only